February 2017

Table of Contents

feb17-cover 

Cover Story

The Risk of Trusting Risk Priority Numbers

By John C. Strong, AbbVie Inc.; Todd S. McDermott, AbbVie Inc.; Oliver Heinzerling, AbbVie Deutschland GmbH & Co. KG; H. Gregg Claycamp, Office of New Animal Drug Evaluation, FDA Center for Veterinary Medicine

The shortcomings of the risk priority number. 

Professional Development

Women in Pharmaceutical Sciences

AAPS Publications

Formulation and Delivery of Macromolecules